| 摘要: |
| 药物性肝损伤(drug induced liver injury, DILI)是导致药物研发中断和临床治疗风险的核心问题,其病理机制与氧化应激系统的失衡密切相关。本文首先阐明了活性氧(Reactive oxygen species,ROS)的产生与毒性及抗氧化防御系统的层级调控机制。进一步地,深入探讨氧化应激与DILI的关联性。最后,总结了靶向氧化应激系统缓解DILI的调控机制与干预策略。本综述整合了氧化应激系统与DILI病理进程的多维度关联,为DILI的预防与治疗提供理论支撑。 |
| 关键词: 氧化应激 药物性肝损伤 活性氧 Nrf2通路 铁死亡 肠道-肝脏轴 |
| DOI:10.13506/j.cnki.jpr.2026.01.009 |
| 基金项目:国家自然科学基金面上项目(No.82074114) |
|
Publication Date:January 26, 2026
|
|
| The role and regulatory mechanism of oxidative stress system in drug hepatotoxicity |
| SHEN Weishuang1,JIANG Zhenzhou1,2 |
| (1.State Key Laboratory of Natural Medicines,New Drug Screening and Pharmacodynamics Evaluation Center,Jiangsu Center for Pharmacodynamics Research and Evaluation,China Pharmaceutical University,Nanjing 210009,China;2.Animal Experimental Center,China Pharmaceutical University,Nanjing 210009,China) |
| Abstract: |
| Drug-induced liver injury (DILI) is a core issue that leads to the interruption of drug development and clinical treatment risks, and its pathological mechanism is closely related to the imbalance of the oxidative stress system.This article first clarifies the generation and toxicity of reactive oxygen species (ROS) and the hierarchical regulatory mechanism of the antioxidant defense system. Further, it deeply explores the correlation between oxidative stress and DILI. Finally, it summarizes the regulatory mechanisms and intervention strategies for targeting the oxidative stress system to alleviate DILI. This review integrates the multi-dimensional correlations between the oxidative stress system and the pathological process of DILI, providing theoretical support for the prevention and treatment of DILI. |
| Key words: Oxidative stress Drug-induced liver injury Reactive oxygen species (ROS) Nrf2 pathway Ferroptosis Gut-liver axis |